-
Our bureaucracy is rightly called the Steel Frame, and you've been the backbone of our fight against COVID-19, says President Ram Nath Kovind
-
The impact will be greater for companies in Maharashtra, Delhi, Rajasthan, Madhya Pradesh and Gujarat, where medical oxygen demand has increased multiple times due to high COVID-19 caseloads
-
To make the admission process quick and easy for patients different state governments have launched dashboards through which you can check bed availability in different hospitals
-
Sudden loss of smell and taste are key indicators of this infection
-
Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe
-
Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more
-
The state Health Department has already written to Covaxin maker Bharat Biotech for procuring 1 crore vaccines.
-
Telengana stood first among the states with 370 tests while Delhi came in at second with 350 tests per one lakh population
-
With the expansion of the vaccination drive from May 1 and reports of more vaccines entering the market, there is hope that the current rise in cases and the overwhelming healthcare systems may get some relief
-
Registering a steady increase for the 42nd day in a row, the active cases have increased to 21,57,538, comprising 13.82 per cent of the total infections, while the national COVID-19 recovery rate has dropped to 85.01 per cent